Abstract
Oxidizing, reducing and, particularly, proteolytic enzymes have proved capable of affecting oxytocin, vasopressin and related peptides. Their action has been studied for several reasons. Neurohypophysial hormones can be distinguished from each other and from unrelated biologically active compounds by their different susceptibility to enzymatic inactivation. Specifically acting enzymes are valuable tools in studies of hormone structure and structure-activity relationship. The occurrence, distribution and biological significance of enzymes, which may be involved in the metabolism of the neurohypophysial hormones under normal and pathological conditions, have of course been of particular interest. Enzymes may possibly play a physiological role in the release of the hormones from the sites of their synthesis or storage. Enzymes may influence the hormone levels in the circulation. Certainly, enzymes are involved in the breakdown of the hormones in various tissues. The insight into the role and mode of action of the enzymes involved in hormone metabolism has stimulated the synthesis of hormone analogues resistant to enzymatic attack and of hormone precursors which will release active hormones in enzyme-catalyzed reactions. Moreover, compounds have been studied which will either inhibit or activate the hormone-degrading enzymes and thus, it is hoped, enhance or depress, respectively, the action of the hormones themselves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- ACTH:
-
adrenocorticotropic hormone
- CAP:
-
cystine aminopeptidase
- EDTA:
-
ethylene diamine tetraacetate
- GSH:
-
glutathione
- GSSG:
-
oxide form of glutathione
- LAP:
-
leucine aminopeptidase
- β-MSH:
-
β-melanocyte-stimulating hormone
- NADP+ :
-
nicotinamide adenine dinucleotide phosphate
- NADPH:
-
reduced form of nicotinamide adenine dinucleotide phosphate
- PCMB:
-
p-chloromercuribenzoate
References
Acher, R.: Évolution moléculaire dans le domaine des hormones neurohypophysaires. VII Giornate Biochim. latine, p. 209-221 (1963).
—, et J. Chauvet: La structure de la vasopressine de boeuf. Biochim. biophys. Acta (Amst.) 12, 487–488 (1953).
—: La structure de la vasopressine de boeuf. Biochim. biophys. Acta (Amst.) 14, 421–429 (1954).
—, M.T. Chauvet, et D. Crepy: Isolement d’une nouvelle hormone neurohypophysaire, l’isotocine, présente chez les poissons osseux. Biochim. biophys. Acta (Amst.) 58, 624–625 (1962).
—, et D. Crepy: Phylogénie des peptides neurohypophysaires: Isolement de la meso-tocine (Ileu8-ocytocine) de la grenouille, intermédiaire entre la Ser4-Ileu8-ocytocine des poissons osseux et l’ocytocine des mammifères. Biochim. biophys. Acta (Amst.) 90, 613–615 (1964).
—,et D. Crepy: Phylogénie des peptides neurohypophysaires: Isolement d’une nouvelle hormone, la glumitocine (Ser4-Gln8-ocytocine) présente chez un poisson cartilagineux, la raie (Raia clavata). Biochim. biophys. Acta (Amst.) 107, 393–396 (1965).
—, et M.-T. Lenci: L’ocytocine et la vasopressine du cheval. Bull. Soc. Chim. biol. (Paris) 40, 2005–2018 (1958).
Acher, R., J. Chauvet, et M.-T. Lenci: Purification et structure de l’ocytocine et de la vasopressine du cheval. Biochim. biophys. Acta (Amst.) 31, 545–548 (1959).
M.-T. Lenci —, et C. Fromageot: Chimie des hormones neurohypophysaires. Ergebn. Physiol. 48, 285–327 (1955).
Afonso, J.F., and N.G. Farnham: Studies of a new electrophoretic zone in labor and the puerperium and in newborn infants. Amer. J. Obstet. Gynec. 84, 199–205 (1962).
Althabe, O., I.C. Arnt, L.A. Branda, and R. Caldeyro-Barcia: Comparison of the milk-ejecting potencies of oxytocin and deamino-oxytocin in lactating women. J. Endocr. 36, 7–14 (1966).
Ames, R.G., and H.B. Van Dyke: Thioglycollate inactivation of posterior pituitary anti-diuretic principle as determined in the rat. Proc. Soc. exp. Biol. (N. Y.) 76, 576–578 (1951).
Anastas’eva, N. V.: Effect of pituitrin, quinine, proserine and phenatine on the activity of blood serum oxytocinase of pregnant female rabbits. Nauchn. Zap. Uzhgorodsk. Gos. Univ. 45, 17–21 (1961). Chem. Abstr. 59, 15811 e (1963).
Aragon, G. T.: An evaluation of plasma pitocinase determination in the toxemias of pregnancy. Amer. J. Obstet. Gynec. 55, 961–966 (1948).
Arimura, A., and T. Yamaguchi: Serum protein-vasopressin binding and its influence on the pressor activity of the hormone. Jap. J. Physiol. 14, 90–101 (1964).
Arst, H.E., R.T. Manning, and M. Delp: Serum leucine aminopeptidase activity: Findings in carcinoma of the pancreas, pregnancy, and other disorders. Amer. J. med. Sci. 238, 598–609 (1959).
Audrain, L., et H. Clauser: Relation entre l’activité physiologique de rocytocine et l’état des son pont disulfure. Biochim. biophys. Acta (Amst.) 30, 191–192 (1958).
—: Mécanisme de l’inactivation de l’ocytocine par le tissu utérin. Biochim. biophys. Acta (Amst.) 38, 494–501 (1960).
Babuna, C., and E. Yenen: Enzymatic determination of placental function. A rapid method. Amer. J. Obstet. Gynec. 95, 925–934 (1966).
Barnafi, L., R. Rosas, T. Pereda, and H. Croxatto: Effect of vasopressin structural modifications on rat renal excretion of Na, K and water. Amer. J. Physiol. 202, 593–596 (1962).
Barnes, A.C., and I.B. Sawyer: Measurements of vasopressinase in maternal and cord blood. Amer. J. Obstet. Gynec. 79, 1053–1057 (1960).
Barth, T., V. Pliška, and I. Rychlík: Chymotryptic and tryptic cleavage of oxytocin and vasopressin. Collection Czech. Chem. Commun. 32, 1058–1063 (1967).
Barth, T., V. Pliška, and I. Rychlík —, and F. Šorm: Enzymic inactivation of oxytocin. V. Purification and some properties of enzymes from human retroplacental serum. Collection Czech. Chem. Commun. 32, 2327–2336 (1967).
Barttk, M., and E. Michnova: Polarographic determination of oxytocinase and a contribution to the characteristics of aminopeptidases. Vet. Med. (Praha) 11, 645-653 (1966). Chem. Abstr. 66, 43882 (1967).
Bartošek, I., V. Pliška, I. Rychlík, and F. Šorm: The inactivation of oxytocin in the liver. The proteolytic splitting. Probl. Evolyutsionnoi i Tekhn. Biokhim., Akad. Nauk Sssr, Inst. Biokhim., 276-286 (1964).
—, I. Rychlík, and F. Šorm: The inactivation of oxytocin in tissues. Proc. 2nd Int. Pharmacol. Meeting, Prague 1963, 10, 185–188 (1964).
Beckman, L., G. Björling, and C. Christodoulou: Pregnancy enzymes and placental polymorphism. II. Leucine aminopeptidase. Acta genet. (Basel) 16, 122–131 (1966a).
C. Christodoulou —: Multiple molecular forms of leucine aminopeptidase in man. Acta genet. (Basel) 16, 223–230 (1966b).
C. Christodoulou —, and M. Grivea: Variations in serum leucine aminopeptidase in pregnant women and in newborn children. Acta Paediat. Scand. 54, 578–580 (1965).
Behal, F. J., R.D. Hamilton, C.B. Kanavage, and E.C. Kelly: Studies on aminopeptidases in human blood. Arch. Biochem. 100, 308–312 (1963).
Beller, F.K., u. U. Göbelsmann: Der Abbau von natürlichem und synthetischem Oxytocin durch Oxytocinase. Klin. Wschr. 36, 1005–1008 (1958).
—: Methodische Probleme der Serumoxytocinase-Bestimmung im Schwangerenserum. Acta endocr. (Kbh.) 31, 467–480 (1959a).
—: Untersuchungen über die Serum-Oxytocinase. Bibl. Gynaec. (Basel) 20, 174–178 (1959b).
—, u. H. Schniz: Quantitative Probleme der Oxytozininaktivierung. Geburtsh. u. Frauen-heilk. 20, 563–569 (1960).
Beránková, Z., I. Rychiík, and F. Šorm: Inhibition of oxytocin inactivation by some pep-tides. Experientia (Basel) 15, 298–299 (1959).
Beránková, Z., I. Rychlík, and F. Šorm: Enzymic inactivation of oxytocin. I. Selective inhibitors of oxytocin inactivation. Collection Czech. Chem. Commun. 25, 2575–2580 (1960).
F. Šorm —: Enzymic inactivation of oxytocin. II. Fission of some peptide fragments of the oxytocin structure and their derivatives by pregnancy serum and liver cell sap. Collection Czech. Chem. Commun. 26, 1708–1715 (1961).
F. Šorm —, and F. Šorm: Enzymic inactivation of oxytocin. III. Desthiooxytocin and S,S’-dibenzyldi-hydrooxytocin as oxytocinase inhibitors and substrates. Collection Czech. Chem. Commun. 26, 2557–2561 (1961).
Beránková-Ksandrová, Z., G.W. Bisset, K. JoŠt, I. Krejčé, V. Pliška, J. Rudinger, I. Rychlík, and F. Šorm: Synthetic analogues to oxytocin acting as hormonogens. Brit. J. Pharmacol. 26, 615–632 (1966).
K. JoŠt, I. Krejčé, V. Pliška, J. Rudinger, I. Rychlík, and F. Šorm —, I. Ryctttík, and F. Šorm: Oxytocin analogues with protracted effects. Proc. 2nd Int. Pharmacol. Meeting, Prague 1963, 10, 181–183 (1964).
Birnie, J.H.: The inactivation of posterior pituitary antidiuretic hormone by liver extracts. Endocrinology 52, 33–38 (1953).
—, K.E. Blackmore, and H. Heller: Changes in water diuresis and vasopressin inactivation in mice fed on protein deficient diets. Experientia (Basel) 8, 30–31 (1952).
Bisset, G.W.: Effect of tyrosinase preparations on oxytocin, vasopressin and bradykinin. Brit. J. Pharmocol. 18, 405–420 (1962).
—: The effect on milk-ejecting activity of modifying two functional groups in oxytocin. In: Proc. 2nd Int. Pharmacol. Meeting, Prague 1963, 10, 21–30 (1964).
Bonow, A., W. Carol, U. S. Wachtel: Die Bestimmung der Serum-Oxytocinase-Aktivität auf chemischem Wege. Zbl. Gynäk. 85, 1537–1542 (1963).
Borov, V. l.: Activity of oxytocinase and cholinesterases at the end of pregancy and during labour. Akusherstwo i Ginekol. 42, 39-42 (1966). Chem. Abstr. 65, 17306f (1966).
Braun-Falco, O., u. K. Salfeld: Über das Verhalten der Leucinaminopeptidase-Aktivität im Blutserum und Blaseninhalt. II. Untersuchungen an Patienten mit Psoriasis, Neuroder-matitis diffusa, Dermatitis, Ekzem und anderen Dermatosen. Arch. klin. exp. Derm. 205, 103–111 (1957).
Bressler, R., and B.R. Forsyth: Serum leucine aminopeptidase activity in normal pregnancy and in patients with hydatidiform mole. New Engl. J. Med. 261, 746–748 (1959).
—,and G. Klatskin: Serum leucine aminopeptidase activity in hepatobiliary and pancreatic disease. J. Lab. clin. Med. 56, 417–430 (1960).
Campbell, B.J., B. Thysen, and F.S. Chu: Peptidase catalyzed hydrolysis of antidiuretic hormone in toad bladder. Life Sci. 4, 2129–2140 (1965).
Camu, F., and V. Conard: Effect de l’ocytocine sur l’inactivation de l’insuline par le rein de rat normal in vitro. Arch. int. Pharmacodyn. 162, 247–252 (1966).
Carballo, M. A.: Discussion remark. In: Oxytocin. Ed. by R. Caldeyro-Barcia and H. Heller. Proc. Int. Symp., Montevideo 1959, 343 (1961).
—, and C. J. Méndez-Bauer: Evolution of oxytocinase during pregnancy and induced labour. Proc. 2nd Uruguayan Congr. Obstet. Ginecol. 2, 300–307 (1957a).
—: Placental origin of oxytocinase. Proc. 2nd Uruguayan Congr. Obstet. Ginec. 2, 308–313 (1957b).
Centaro, A., P. Periti, and G. De Laurentiis: Oxytocin and oxytocinase activity of the blood and myometrium of women in labor. Riv. Ostet. Ginec. 16, 297–326 (1961).
Cespedes, J., and H. Croxatto: Action of oxidants (thiol antagonists) on the oxytocinase activity of blood serum. Bol. Soc. Biol. Santiago 7, 43–46 (1949).
Chauvet, J., M.-T. Chauvet, et R. Acher: Les hormones neurohypophysaires des mammifêres: Isolement et caractérisation de l’ocytocine et de la vasopressine de la balaine (Ba-laenoptera physedus L.) Bull. Soc. Chim. Biol. (Paris) 45, 1369–1378 (1963).
Christlieb, M.: Über den Abbau von Oxytocin und Vasopressin in vitro. Arch. Exp. Pathol. Pharmakol. 194, 44–51 (1940).
Čihař, M., Z. Beránková, I. Rychlík, and F. Šorm: Enzymic inactivation of oxytocin. IV. Characterization of purified preparations of serum oxytocinase. Collection Czech. Chem. Commun. 26, 2632–2642 (1961).
Cooper, D.W.: A serum protein present in pregnant women. Nature (Lond.) 200, 892 (1963).
Crewther, W.G., and F.G. Lennox: Preparation of crystals containing protease from Aspergillus oryzae. Nature (Lond.) 165, 680 (1950).
Croxatto, H.: Hypertensinase action. Inactivation of hypertensin and pressor and oxytocic principles of the posterior pituitary in the organism. Rev. Med. Aliment. (Santiago) 5, 259–271 (1942/1943).
—, J. Alliende, and R. Croxatto: Action of aminopolypeptidase of yeast and hypertensinase of kidney extracts on the oxytocic principle of the posterior pituitary. Rev. Med. Aliment. (Santiago) 5, 228–229 (1942/43a).
Croxatto, H., J. Alliende, and R. Croxatto: Action of trypsin and chymotrypsin on the oxytocic principle of the posterior pituitary. Rev. Med. Aliment. (Santiago) 5, 230–231 (1942/43b).
R. Croxatto —, W. Badia, and R. Croxatto: Effect of fibrinolysin on oxytocin, vasopressin and hyper-tensinogen. Proc. Soc. exp. Biol. (N. Y.) 69, 422–425 (1948).
R. Croxatto —, and J. Cespedes: Action of cytochrome C on the oxytocinase and vasopressinase activity of blood serum. Bol. Soc. Biol. Santiago 7, 54–57 (1950).
R. Croxatto —, and S. Daza: The effect of thiosorbitol on the inactivation of oxytocin and vasopressin by blood plasma. Bol. Soc. Biol. Santiago 8, 96–100 (1951).
R. Croxatto —, R. Croxatto, and J. Alliende: Destruction of oxytocin by the aminopeptidase of beer yeast and by extracts of hypertensive kidneys. Rev. Soc. argent. Biol. 18, 441–453 (1942).
R. Croxatto —, G. Illanes, and H. Salvestrini: Action of chymotrypsin and trypsin on hypertensin and pressor and oxytocic principles of the posterior pituitary. Rev. Med. Aliment. (Santiago) 5, 300–302 (1942/1943).
R. Croxatto, G. Illanes —, and M. Reyes: The effect of hypertensin on the inactivation of oxytocin by the serum of pregnant women. Science 108, 658–659 (1948).
R. Croxatto —, and M. Rioseco: Action of carboxypeptidase on pepsitensin, vasopressin and oxytocin. Rev. Soc. argent. Biol. 21, 23–29 (1945).
R. Croxatto — C. Donoso, and R. Croxatto: Effect of amino acids on the inactivation of oxytocin by kidney hypertensinase extracts. Bol. Soc. Biol. Santiago 5, 51–53 (1948a).
R. Croxatto —, G. Illanes, H. Salvestrini, and R. Croxatto: Action of aminopolypeptidase and hypertensinase extracts from kidney on the pressor principle of the post-pituitary. Rev. Med. Aliment. (Santiago) 5, 226–228 (1942/1943).
R. Croxatto —, and J. De la Maza: Action of tyrosinase (extracts of Psalliota Campestris) on vasopressin. Bol. Soc. Biol. Santiago 2, 46–48 (1944).
—, T. Pereda, and B. Zamorano: Oxytocic substances in blood serum. In: Oxytocin. Proc. Int. Symp., Montevideo 1959, 412-424 (Publ. 1961).
R. Croxatto —, and M. Reyes: Effect of cysteine and glutathione on the oxytocinase activity of blood plasma. Bol. Soc. Biol. Santiago 5, 80–82 (1948).
R. Croxatto —, R. Rosas, and L. Barnafi: Effect of vasopressin and oxytocin on excretion of water and electrolytes (Na, Cl, and K) in the albino rat. Acta physiol. lat.-amer. 6, 147–152 (1956).
R. Croxatto —, A. Trautmann, and R. Croxatto: Destruction of hypertensin and the pressor and oxytocic principles of the posterior pituitary by extracts of red blood cells and kidney. Rev. Med. Aliment. (Santiago) 5, 305–308 (1943).
R. Croxatto —, C. Vera, and L. Barnafi: Inactivation of antidiuretic hormone by blood serum of the pregnant woman. Proc. Soc. exp. Biol. (N. Y) 83, 784–786 (1953).
Croxatto, R., H. Croxatto, and J. Sorolla: Aminopeptidase character of hypertensinase. Rev. Med. Aliment. (Santiago) 5, 135–136 (1942/1943).
J. Sorolla —, C. Donoso, and H. Croxatto: Effect of amino acids on the inactivation of vasopressin by kidney hypertensinase extracts. Bol. Soc. Biol. (Santiago) 5, 54–56 (1948b).
Dale, H.H., and H.W. Dudley: On the pituitary active principles and histamine. J. Pharmacol, exp. Ther. 18, 27–42 (1921).
Dicker, S.E.: The inactivation of vasopressin and of oxytocin, in vitro. In: Polypeptides which affect smooth muscles and blood vessels, p. 79-82. Ed. by M. Schachter. Proc. Symp., London 1959, (Pub. 1960).
—, and M. Ginsburg: Some observations on the antidiuretic activity of rat serum. Brit. J. Pharmacol. 5, 497–504 (1950).
—, and A. L. Greenbaum: The degree of inactivation of the antidiuretic activity of vasopressin by the kidneys and the liver of rats. J. Physiol. (Lond.) 126, 116–123 (1954).
—: Inactivation of the antidiuretic activity of vasopressin by tissue homogenates. J. Physiol. (Lond.) 132, 199–212 (1956).
—: The destruction of the antidiuretic activity of vasopressin by SH active compounds. J. Physiol. (Lond.) 141, 107–116 (1958).
—, and C. Tyler: Inactivation of oxytocin and vasopressin by blood plasma of pregnant women. J. Obstet. Gynaec. Brit. Emp. 63, 690–696 (1956).
—, and G.A. Whyley: Inactivation of oxytocin by plasma of pregnant women. J. Physiol. (Lond.) 146, 33–34 P (1959a).
—: Inactivation of oxytocin by plasma of pregnant women. J. Obstet. Gynaec. Brit. Emp. 66, 605–609 (1959b).
— The role of oxytocinase during pregnancy in man and animals. Acta endocr. (Kbh.) 34, (Suppl. 51), 145 (1960).
Dieckmann, W. J., G.F. Egenolf, B. Morley, and R.E. Pottinger: The inactivation of the antidiuretic hormone of the posterior pituitary gland by blood from pregnant patients. Amer. J. Obstet. Gynec. 60, 1043–1050 (1950).
Dlouhá, H., M. Kraus, J. Křeček, and V. Pliška: Sensitivity of rats to vasopressin in the weaning period. Physiol. bohemoslov. 14, 217–224 (1965).
Drewntak, K.: Evaluation of a biochemical method of determining the term of delivery. Ginek. pol. 35, 27–32 (1964a).
—: Clinical evaluation of the biochemical method of determining the term of delivery. In: Oxytocin and its analogues, p. 55-58. Ed. by R. Klimek and W. Krol. Polish Endocr. Soc, Krakow (1964b).
Dudley, H.W.: Some observations on the active principles of the pituitary gland. J. Pharmacol, exp. Ther. 14, 295–312 (1919).
Van Dyke, H.B., B.F. Chow, R.O. Greep, and A. Rothen: The isolation of a protein from the pars neuralis of the ox pituitary with constant oxytocic, pressor and diuresis-inhibiting activities. J. Pharmacol, exp. Ther. 74, 190–209 (1942).
Ehrensing, R.H.: Plasma oxytocinase, cystine and leucine naphthylamidases of snake, turtle and chicken. Proc. Soc. exp. Biol. (N. Y.) 117, 370–373 (1964).
El-Kammah, B.M., and H. Tuppy: Unpublished experiments.
Elliott, D.F., and W.S. Peart: The amino acid sequence in a hypertensin. Biochem. J. 65, 246–254 (1957).
Embrey, M. P.: The action of desamino-oxytocin on the human pregnant uterus. J. Endocr. 31, 185–189 (1965).
Eversole, W. J., J.H. Birnie, and R. Gaunt: Inactivation of posterior pituitary antidiuretic hormone by the liver. Endocrinology 45, 378–382 (1949).
Fekete, K.: Beiträge zur Physiologie der Gravidität. Endokrinologie 7, 364–369 (1930).
—: Gibt es während der Schwangerschaft ein aktives Hypophysen-Hinterlappenhormon im Blute? Endokrinologie 10, 16–23 (1932).
—: Beiträge zur Erklärung des Geburtseintrittes. Endokrinologie 12, 183–192 (1933).
Folk, J.E., and P.W. Cole: Chymotrypsin C. II. Enzymatic specificity toward several poly-peptides. J. biol. Chem. 240, 193–197 (1965).
Fraser, A. M.: The effect of arginase and of tyrosinase on the activity and composition of posterior pituitary extracts. Rev. canad. Biol. 9, 54–61 (1950).
Freudenberg, K., E. Weiss U. H. Biller: Notiz über Oxytocin. Z. Physiol. Chem. 233, 172–173 (1935).
U. H. Biller —, u. H. Eyer: Über Insulin und Pitutocin. Naturwissenschaften 20, 685 (1932).
Fried, R., u. L. Wüst: Über ein Oxytocin-abbauendes Ferment aus Schweineovarien. Naturwissenschaften 41, 238 (1954).
Fuhrmann, K.: Kolorimetrische Bestimmung und histochemischer Nachweis der Aminopep-tidase an Geweben weiblicher Genitalorgane. Zbl. Gynäk. 81, 1105–1123 (1959).
Fylling, P.: Serum and plasma oxytocinase activity during induction of labour. Acta obstet, gynec. scand. 42, 227–239 (1963).
—: Plasma oxytocinase activity, oestriol and pregnanediol excretion and the effect of induction of labour. Acta obstet, gynec. scand. 43, 58–63 (1964 a).
—: Plasma oxytocinase activity following a single injection of pitocin. Acta obstet, gynec. scand. 43, 103–106 (1964b).
—: Serum and plasma leucine aminopeptidase activity during induction of labor. Scand. J. clin. Lab. Invest. 16, 172–176 (1964c).
Ginsburg, M., H. Heller, and S.M. A. Zaidi: Re-appraisal of the evidence for the metabolic conversion of vasopressin into a less active derivative. Nature (Lond.) 178,803–804 (1956).
—, and M.W. Smith: The fate of oxytocin in male and female rats. Brit. J. Pharmacol. 14, 327–333 (1959).
Di Girolamo, M., D. Rudman, M.F. Malkin, and L.A. Garcia: Inactivation of insulin by adipose tissue. Diabetes 14, 87–92 (1965).
Glendening, M.B., M.A. Titus, S.A. Schroeder, G. Mohun, and E.W. Page: The destruction of oxytocin and vasopressin by the aminopeptidases in sera from pregnant women. Amer. J. Obstet. Gynec. 92, 814–820 (1965).
Goebelsmann, U., and F.K. Beller: Separation of cystine-aminopeptidase and leucine-aminopeptidase and their determination in pregnant and nonpregnant women. Z. klin. Chem. 3, 49–54 (1965).
Golubow, J., W. Y. Chan, and V. Du Vigneaud: Effect of human pregnancy serum on avian depressor activities of oxytocin and desamino-oxytocin. Proc. Soc. exp. Biol. (N. Y.) 113, 113–115 (1963).
—, and V. Du Vigneaud: Comparison of susceptibility of oxytocin and desamino-oxytocin to inactivation by leucine aminopeptidase and α-chymotrypsin. Proc. Soc. exp. Biol. (N.Y.) 112, 218–219 (1963).
González-Panizza, V.H., Y. Sica-Blanco, and C. Méndez-Bauer: The fate of injected oxytocin in the pregnant woman near term. In: Oxytocin, p. 347-357. Ed. by R. Caldeyro-Barcia and H. Heller. Proc. Int. Symp., Montevideo 1959 (1961).
Green, M.N., K.-C. Tsou, R. Bressler, and A.M. Seligman: The colorimetric determination of leucine aminopeptidase activity with L-leucine-ß-naphthylamide hydrochloride. Arch. Biochem. 57, 458–474 (1955).
Gulland, J.M., and T.F. Macrae: The action of proteolytic enzymes on the oxytocic principle of the pituitary gland. Nature (Lond.) 131, 470 (1933a).
—: The oxytocic hormone of the posterior lobe of the pituitary gland. III. The action of preparations of plant proteolytic enzymes. Biochem. J. 27, 1237–1247 (1933b).
—: The oxytocic hormone of the posterior lobe of the pituitary gland. IV. The action of preparations of animal proteolytic enzymes, and some observations on the nature of the hormone. Biochem. J. 27, 1383–1393 (1933c).
Güntelberg, A.V., and M. Ottesen: Preparation of crystals containing the plakalbumin-forming enzyme from Bacillus subtilis. Nature (Lond.) 170, 802 (1952).
Haller, E.W., H. Sachs, N. Sperelakis, and L. Share: Release of vasopressin from isolated guinea pig posterior pituitaries. Amer. J. Physiol. 209, 79–83 (1965).
Hankiss, J.E., M. Keszthelyi, and P. Demény: Inactivation of vasopressin by heart muscle. Tohoku J. exp. Med. 87, 168–174 (1965).
Hanon, F., and M. Brunaud: Determinism of uterine contraction at parturition. C. R. Soc. Biol. (Paris) 141, 163–164 (1947).
Hanson, H., U. H.G. Mannsfeldt: Zur Aktivitätsbestimmung der Serum-Oxytocinase des menschlichen Schwangeren-Serums unter Verwendung chromogener Substrate. In prepn. (1967a). Untersuchungen über die Angreifbarkeit von Serum-Oxytocinase-Substraten durch Gewebs-Enzyme („Gewebs-Oxytocinase“) tierischer Organe. In prepn. (1967b). Über die Humanplacenta als Synthese-Organ der schwangerschaftsspezifischen Serum-Oxytocinase des Menschen. In prepn. (1967 c)
Hardy, S.M., and J.M. Ritchie: Determination of serum oxytocinase (l-cystine-aminopepti-dase) activity. Nature (Lond.) 209, 76–77 (1966).
Hashimoto, T.: Studies on l-cystine-aminopeptidase. I. Biochemical aspect. J. Jap. obstet. gynaec. Soc. 8, 87–95 (1961a).
—: Studies on l-cystine-aminopeptidase. II. Clinical observations. J. Jap. obstet, gynaec. Soc. 8,96–104 (1961b)
Hawker, R.W.: Inactivation of antidiuretic hormone and oxytocin during pregnancy. Quart. J. exp. Physiol. 41, 301–308 (1956).
—: Antidiuretic substance (ADS) in normal pregnancy and pre-eclamptic toxaemia. J. Endocr. 14, 400–410 (1957).
—: Oxytocin and an unidentified oxytocic substance in extracts of blood. In: Oxytocin, 425-436. Proc. Int. Symp., Montevideo 1959 (Publ. 1961).
—, and P.A. Robertson: Oxytocin and lactation. J. clin. Endocr. 17, 448–451 (1957).
—: Are there two oxytocic hormones? Med. J. Aust. 1958 I, 671–672.
—, C.F. Walmsley, V. S. Roberts, and P. A. Robertson: Further observations on oxytocin and oxytocic substance. Med. J. Aust. 1959 I, 460–461.
Heller, H.: The metabolism and fate of the neurohypophysial principles. In: The neurohypo-physis, p. 77–96. Ed. by H. Heller. London: Butterworths Scientific Publications (1957).
—: Inactivation of vasopressin and oxytocin in vivo. In: Polypeptides which affect smooth muscles and blood vessels, p. 59-69. Ed. by M. Schachter. Proc. Symp., London 1959 (Pub. 1960).
—, and F. F. Urban: The fate of the antidiuretic principle of postpituitary extracts in vivo and in vitro. J. Physiol. (London) 85, 502–518 (1935).
—, and S.M.A. Zaidi: The metabolism of exogenous and endogenous antidiuretic hormone in the kidney and liver in vivo. Brit. J. Pharmacol. 12, 284–292 (1957).
Hess, R.: Arylamidase activity related to angiotensinase. Biochim. biophys. Acta (Amst.) 99, 316–324 (1965).
Hill, R.L., and E.L. Smith: Leucine aminopeptidase. VII. Action on long chain polypeptides and proteins. J. biol. Chem. 228, 577–600 (1957).
—: Complete hydrolysis of glucagon by leucine aminopeptidase. Biochim. biophys. Acta (Amst.) 31, 257–258 (1959).
Hilton, J.G., and R.F. Johnson: Changes in blood oxytocinase during parturition. Amer. J. Obstet. Gynec. 78, 479–482 (1959).
Hirschfeld, J., and U. Söderberg: Immuno-electrophoretic demonstration of precipitating components in sera from pregnant women. Nature (Lond.) 187, 332–333 (1960).
Hooper, K. C.: The action of inhibitors on enzymes from human placentae. J. Physiol. (London) 148, 283–290 (1959).
—: The preparation of soluble vasopressinase from human placenta. Biochem. J. 74, 297–300 (1960a).
Hooper, K. C.: Some properties of enzymes destroying oxytocin and vasopressin. In: Poly-peptides which affect smooth muscles and blood vessels, p. 83-86. Ed. by M. Schachter. Proc. Symp. (London) 1959 (Pub. 1960b).
—: The preparation and properties of cystine esterase. Biochem. J. 78, 409–412 (1961a).
—: The catabolism of bradykinin, oxytocin, substance P and vasopressin by homogenate of dog hypothalamus. Biochem. J. 81, 44 P (1961b).
—: The catabolism of some physiologically active polypeptides by homogenate of dog hypothalamus. Biochem. J. 83, 511–517 (1962a).
—: The intracellular distribution of enzymes inactivating oxytocin in the dog hypothalamus. Biochem. J. 85, 8 P (1962b).
—: The enzymic inactivation of some physiologically active polypeptides by different parts of the nervous system. Biochem. J. 88, 398–404 (1963a).
—: The effect of pregnancy on the distribution of hypothalamic enzymes inactivating oxytocin. Biochem. J. 88, 67 P (1963b).
—: The distribution of hypothalamic peptidases in pregnant and non-pregnant dogs. Biochem. J. 90, 584–587 (1964).
—: Some observations on the behaviour of hypothalamic enzymes during the time of blastocyst implantation in the rabbit. Biochem. J. 99, 128–132 (1966a).
—: The metabolism of oxytocin during lactation in the rabbit. Biochem. J. 100, 823–826 (1966b).
— and D.C. Jessup: The distribution of enzymes destroying oxytocin and vasopressin in human placentae. J. Physiol. (Lond.) 146, 539–549 (1959).
Hopsu, V.K., S. Ruponen, and S. Talanti: Leucine aminopeptidase in the placenta of the rat. Acta histochem. (Jena) 12, 305–309 (1961).
Hugtjenin, R.L., and R.A. Boissonnas: Synthèse de la (N-méthyl-Tyr)2-oxytocine. Helv. chim. Acta 44, 213–231 (1961).
Ichaliotis, S.D., and Th. C. Lambrinopotjlos: Preeclampsia associated with decrease in serum oxytocinase. Obstet, and Gynec. 24, 659–661 (1964).
—: Serum oxytocinase in twin pregnancy. Obstet, and Gynec. 25, 270–272 (1965).
Itoh, S., and T. Kikuchi: Inactivation of antidiuretic activity of vasopressin by hypothalamic tissue in the presence of pyridoxal. Jap. J. Physiol. 9, 401–405 (1959).
James, N.T.: Histochemical demonstration of oxytocinase in the human placenta. Nature (Lond.) 210, 1276–1277 (1966).
Johnson, M.J.: Isolation and properties of a pure yeast polypeptidase. J. biol. Chem. 137, 575–586 (1941).
Jones, A.M., and W. Schlapp: The action and fate of injected posterior pituitary extracts in the decapitated cat. J. Physiol. (Lond.) 87, 144–157 (1936).
Jošt, K., and J. Rudinger: Amino acids and peptides. XXXIV. Some peptides of S-ben-zylcysteine. Collection Czech. Chem. Commun. 26, 2345–2354 (1961).
—, and F. Šorm: Analogues of oxytocin exerting protracted biological effects. Collection Czech. Chem. Commun. 28, 2021–2030 (1963).
Kanazawa, T.: Supplementary studies on blood pitocinase. J. Jap. obstet. gynaec. Soc. 1, 42–72 (1954).
Karlin, A.: The in vitro release by the toad bladder of an inhibitor of oxytocin. Biochem. biophys. Res. Commun. 11, 44–49 (1963).
Kasafirek, E., K. Jost, J. Rudinger, and F. Srm: Amino acids and peptides. LIV. Synthesis of further extended-chain analogues of oxytocin. Collection Czech. Chem. Commun. 30, 2600–2608 (1965).
—, V. Rábek, J. Rudinger, and F. Šorm: Amino acids and peptides. Lxvi. Synthesis of ten extended-chain analogues of lysine vasopressin. Collection Czech. Chem. Commun. 31, 4581–4591 (1966).
Katzen, H. M., and D. Stetten: Hepatic glutathione-insulin transhydrogenase. Diabetes 11, 271–280 (1962).
—, F. Tietze, and D. Stetten: Further studies on the properties of hepatic glutathione-insulin transhydrogenase. J. biol. Chem. 238, 1006–1011 (1963).
Kazda, S.: Discussion remark. Proc. 2nd Int. Pharmacol. Meeting, Prague 1963,10,150 (1964).
Kleiner, H., et M. Van Rymenant: Détermination placentaire de l’ocytocinase sérique dans l’insuffisance et la mort fétale “in utero”. Rev. franç. Étud. clin. biol. 9, 321–323 (1964).
Klimek, R.: Discussion remark. Proc. 2nd. Int. Pharmacol. Meeting, Prague 1963,10, 150 to 151 (1964a).
—: Pregnancy and delivery in the light of studies on the oxytocin-oxytocinase system. In: Oxytocin and its analogues, p. 27-38. Ed. by R. Klimek and W. Krol, Polish Endocrinol. Soc, Krakow (1964b).
—, u. M. Pietrzycka: Biochemische Methode zur Bestimmung der Oxytocinase und ihre klinische Bewertung. Clin. chim. Acta 6, 326–330 (1961).
Klimek, R., M. Pietrzycka, and J. Grochowski: The influence of operative trauma on blood levels of oxytocinase. Clin. chim. Acta 7, 398–402 (1962).
Kowlessar, O.D., L.J. Haeffner, and E.M. Riley: Localization of serum leucine amino-peptidase, 5-nucleotidase, and nonspecific alkaline phosphatase by starch-gel electropho-resis: Clinical and biochemical significance in disease states. Ann. N. Y. Acad. Sci. 94, 836–843 (1961).
Lambrinopoulos, T. C.: Prolonged pregnancy associated with increase in serum oxytocinase. Obstet, and Gynec. 23, 780–782 (1964).
Larson, E.: Tolerance and fate of the pressor principle of posterior pituitary extract in anesthetized animals. J. Pharmacol, exp. Ther. 62, 346–362 (1938).
—: Fate of the injected oxytocic principle of posterior pituitary in anesthetized cats and dogs. J. Pharmacol, exp. Ther. 67, 175–186 (1939).
Lawler, H.C., S.P. Taylor, A.M. Swan, and V. DF Vigneaud: Prensence of glutamine and asparagine in enzymatic hydrolysates of oxytocin and vasopressin. Proc. Soc. exp. Biol. (N.Y.). 87, 550–552 (1954).
—, and V. Du Vigneaud: Enzymatic evidence for intrinsic oxytocic activity of the pressor-antidiuretic hormone. Proc. Soc. exp. Biol. (N. Y.) 84, 114–116 (1953).
Leblová, S., and I. Rychlík: Inhibition of enzymic inactivation of oxytocin by amino acids. Collection Czech. Chem. Commun. 25, 2926–2929 (1960).
Lettow, E., u. Ch. Jaeger: Bestimmung der Leucin-Aminopeptidase-Aktivität im Seru trächtiger Hündinnen. Zbl. Vet.-Med. 12, 388–394 (1965).
Lewis, J.: Serum leucine aminopeptidase values in patients with trophoblastic tumors and in normal pregnancy. Amer. J. Obstet. Gynec. 84, 1407–1411 (1962).
Linderstrøm-Lang, K., and M. Ottesen: Formation of plakalbumin from ovalbumin. C. R. Lab. Carlsberg, Ser. Chim. 26, 403 (1949).
Lineweaver, H., and D. Burk: The determination of enzyme dissociation constants. J. Amer. chem. Soc. 56, 658–666 (1934).
MacLaren, J. A., R.D. Thornes, C.C. Roby, and D.E. Reid: An immunologic characteristic of the serum of normal pregnancy. Amer. J. Obstet. Gynec. 78, 939–946 (1959).
Manunta, G.: On the inactivation of oxytocin in the cow. Boll. Soc. ital. Biol. Sper. 36, 281–284 (1960).
—, and A. Marongiu: On the inactivation of oxytocin in Bos taurus, Equus caballus, Equus asinus, Ovis aries, Canis familiaris, Sus scrofa, Lepus cuniculus, Cavia cobaya, Mus nor-vegicus albinus, Mus musculus, Gallus gallus and Columbia livia. Boll. Soc. ital. Biol. Sper. 37, 1–2 (1961).
Martin, G.J., J.N. Moss, and R.D. Smyth: Vasopressin potentiation and simulation by bromelain. Arch. int. Pharmacodyn. 152, 445–449 (1964).
Martin, P.J., and H.O. Schild: Effect of thiols on oxytocin and vasopressin receptors. Nature (Lond.) 196, 382–383 (1962). Pharmacological antagonism between SH compounds and S-S polypeptides. Proc. 2nd Int. Pharmacol. Meeting, Prague 1963, 10, 109-116 (1964).
De la Maza, J., and H. Croxatto: Action of tyrosinase on oxytocin. Bol. Soc. Biol. Santiago 2, 23–26 (1944).
McCartney, C.P., F. J. Vallach, and R.E. Pottinger: Further studies on the inactivation of pitressin antidiuretic effect by the blood of pregnant women. Amer. J. Obstet. Gynec. 63, 847–853 (1952).
Melander, S.: Plasma oxytocinase activity. A methodological and clinical study with special reference to pregnancy. Acta endocr. (Kbh.) 49, Suppl. 96, 1–94 (1965).
Melander, S.E.J.: Oxytocinase activity of plasma of pregnant women. Nature (Lond.) 191, 176–177 (1961).
Méndez-Bauer, C.J.: In: Oxytocin, p. 342. Proc. Int. Symp., Montevideo 1959 (Pub. 1961).
—, and M.A. Carballo: Method for the quantitative determination of oxytocin. Proc. 2nd Congr. Urug. Obstet. Gynec. 2, 291–299 (1957).
— —,H.M. Cabot, C.E. Negreiros De Paiva, and V.H. Gonzälez-Panizza: Studies on plasma oxytocinase. In: Oxytocin, Proc. Int. Symp., Montevideo 1959,325-335 (Pub. 1961).
Mtlani, L.: Effect of pregnant blood serum on the uteromotor activity of the amniotic fluid. Boll. Soc. ital. Biol. Sper. 27, 679–682 (1951).
—, and C. Pinetti: Pitocinase. I. Attempts to influence the inactivation of oxytocin by blood serum of the pregnant woman. Boll. Soc. ital. Biol. Sper. 27, 1–4 (1951).
Miller, Z.B., E. Naor, L. Milkovtch, and W.M. Schmidt: Serum levels of cystine aminopeptidase, leucine aminopeptidase, and alkaline phosphatase in single and twin pregnancies. Obstet, and Gynec. 24, 707–715 (1964).
Müller-Hartbtjrg, W., H. Nesvadba U. H. Tuppy: Die Anwendung einer chemischen Methode zur Bestimmung des Oxytocinasespiegels im Schwangerenserum. Arch. Gynäk. 191, 442–456 (1959).
Munsick, R.A., W.H. Sawyer, and H.B. Van Dyke: Avian neurohypophysial hormones: pharmacological properties and tentative identification. Endocrinology 66, 860–871 (1960).
Nagatsu, I., L. Gillespie, J.M. George, J.E. Folk, and G.G. Glenner: Serum aminopepti-dases, “angiotensinase”, and hypertension. II. Amino acid ß-naphthylamide hydrolysis by normal and hypertensive serum. Biochem. Pharmacol. 14, 853–861 (1965).
Namiki, H. (1952), see Kanazawa (1954).
Page, E.W.: The value of plasma pitocinase determinations in obstetrics. Amer. J. Obstet. Gynec. 52, 1014–1022 (1946).
—: A blood test for estimating the week of pregnancy. Science 105, 292–293 (1947).
—, M.A. Titus, G. Mohun, and M.B. Glendening: The origin and distribution of oxytoci-nase. Amer. J. Obstet. Gynec. 82, 1090–1095 (1961).
Periti, P., A. Centaro, and G. De Laurenths: Oxytocinase activity in the uterus of women in labor and in different conditions of pregnancy. Boll. Soc. ital. Biol. Sper. 37, 453–455 (1961a).
G. De Laurenths —: Oxytocinase in the blood of women in labor. Boll. Soc. ital. Biol. Sper. 37, 455–457 (1961b).
Perks, A.M., M.H.I. Dodd, and J.M. Dodd: A neurohypophyseal principle in the elasmo-branch pituitary. Nature (Lond.) 185, 850–851 (1960).
—, and W.H. Sawyer: A new neurohypophyseal principle in an elasmobranch, Raia ocellata. Nature (Lond.) 205, 154–156 (1965).
Pliška, V., T. Barth, and I. Rychlík: Effect of human serum oxytocinase on the antidiu-retic action of lysine vasopressin and oxytocin in the rat. Experientia (Basel) 23, 196–197 (1967).
Preddie, E.C.: Structure of a large polypeptide of bovine posterior pituitary tissue. J. biol. Chem. 240, 4194–4203 (1965).
—, and M. Saffran: Isolation of a large polypeptide from bovine posterior pituitary powder. J. biol. Chem. 240, 4189–4193 (1965).
Riad, A.M.: Studies on pregnancy serum cystine aminopeptidase activity’ oxytocinase†. J. Obstet. Gynaec. Brit. Emp. 69, 409–416 (1962).
—: Changes in pregnancy serum oxytocinase activity during oxytocin infusion and their physiological significance. J. Obstet. Gynaec. Brit. Cwlth 73, 977–982 (1966).
—, and F.J. Scandrett: Distribution of cystine aminopeptidase activity (oxytocinase) in human pregnancy sera. Nature (Lond.) 193, 372–373 (1962).
Riniker, B., u. R. Schwyzer: Die sterische Einheitlichkeit des synthetischen Val5-Hyper-tensin II-Asp1-ß-amids. Helv. chim. Acta 44, 658–667 (1961).
Rittner, Ch.: Über den immunologischen Nachweis von Aminopeptidasen, insbesondere der Oxytocinase (Cystinaminopeptidase). Z. Immun.-Forsch. 131, 422–433 (1966).
Roth, M.: Fluorimetric assay of some peptidases. West European Symp. Clin. Chem. 4, 10–17 (1964). Chem. Abstr. 63, 2054 g (1965).
Royce, P.C., and G. Sayers: Corticotropin releasing activity of a pepsin labile factor in the hypothalamus. Proc. Soc. exp. Biol. (N.Y.) 98, 677–680 (1958).
Rudman, D., M.F. Malkin, S.J. Brown, L.A. Garcia, and L.L. Abell: Inactivation of adrenocorticotropin, α and β-melanocy te-stimulating hormones, vasopressin, and pituitary fraction H by adipose tissue. J. Lipid Res. 5, 38–45 (1964).
—, L.A. Garcia, M. D.I. Girolamo, and L.L. Abell: Inactivation of the adipokinetic property of adrenocorticotropin, ßmelanocyte-stimulating hormone, vasopressin and pituitary fraction H by tissues of the rat and rabbit. Endocrinology 75, 867–876 (1964).
Rychlík, I.: Inactivation of oxytocin and vasopressin by tissue enzymes: a basis for the design of analogues. Proc. 2nd. Int. Pharmacol. Meeting, Prague 1963, 10, 153–162 (1964).
Rydén, G.: Cystine aminopeptidase and oxytocinase activity in pregnancy. A comparative study in human and rat tissues. Acta obstet, gynec. scand. 45, Suppl. 3 (1966).
—, and I. Sjöholm: Assay of oxytocin by rat mammary gland in vitro. Brit. J. Pharmacol. 19, 136–141 (1962).
Saameli, K.: Quantitative comparison between oxytocin and four related neurohypophysial peptides on the human uterus in situ. Brit. J. Pharmacol. 23, 176–183 (1964).
Sachs, H., and Y. Takabatake: Evidence for a precursor in vasopressin biosynthesis. Endocrinology 75, 943–948 (1964).
Sasaki, N.: Antidiuretic substance in the bile. IX. The inactivation by a rat liver extract. Yamaguchi Igaku 9, 116–117 (1960).
Sawyer, W. H.: Inactivation of oxytocin by homogenates of uteri and other tissues from normal and pregnant rats. Proc. Soc. exp. Biol. (N. Y.) 87, 463–465 (1954).
Scalabrino, L., and R. Caracristi: Inhibitory action of liver homogenates in vitro toward oxytocin. Arch. Stud. Fisiopat. Ricambio 24, 525–530 (1960).
Scalabrino, L., R. Caracristi, and P. Pebiti: Liver oxytocinase during experimental cirrhosis by carbon tetrachloride in the rabbit. Boll. Soc. ital. Biol. Sper. 37, 450–452 (1961).
Schally, A.V., and J.F. Barrett: On the configuration of a lysine-vasopressin dimer. J. Amer. chem. Soc. 87, 2497–2499 (1965).
—, C.Y. Bowers, A. Kuroshima, Y. Ishida, W.H. Carter, and T.W. Redding: Effect of lysine-vasopressin dimers on blood pressure and some endocrine functions. Amer. J. Physiol. 207, 378–384 (1964).
—, and R. Guillemin: Some biological and chemical properties of a lysine-vasopressin dimer. J. biol. Chem. 239, 1038–1041 (1964).
—, A. J. Kastin, J.F. Barrett, W.H. Carter, C.Y. Bowers, and W.F. White: On vasode-pressor activity in the hypothalamus. Biochem. Pharmacol. 15, 1805–1811 (1966).
Schockaert, J.-A., and J. Lambillon: Sur la présence d’une substance antagoniste de la vasopressine dans le sérum de femmes enceintes. C. R. Soc. Biol. (Paris) 119, 1194–1197 (1935).
—: Observations complémentaires sur la substance antagoniste de la vasopressine dans le sérum de la femme enceinte. C. R. Soc. Biol. (Paris) 122, 478–480 (1936a).
—: Spécificité de la substance inhibant l’action hypertensive de la vasopressine dans le sérum de la femme enceinte. C. R. Soc. Biol. (Paris) 122, 481–484 (1936b).
Schwartz, I.L., and L.M. Livingston: Cellular and molecular aspects of the antidiuretic action of vasopressins and related peptides. Vitam. and Horm. 22, 261–358 (1964).
—, H. Rasmtjssen, M.A. Schoessler, L. Silver, and C.T.O. Fong: Relation of chemical attachment to physiological action of vasopressin. Proc. nat. Acad. Sci. (Wash.) 46, 1288 to 1298 (1960).
Sciarra, J.J., and D.A. Burress: Serum leucine aminopeptidase in twin pregnancy. Proc. Soc. exp. Biol. (N. Y.) 104, 712–713 (1960).
Segura-Cardona, R.: Inhibition of angiotensin, bradykinin and oxytocin by extracts from several organs. Rev. esp. Fisiol. 20, 27–35 (1964).
Semm, K.: Die klinische Bedeutung der Oxytocinasebestimmung. Klin. Wschr. 33, 817–818 (1955).
—: Der Abbau von synthetischem Oxytocin. Naturwissenschaften 44, 424 (1957).
—: Die Bildungsstätte der Serum-Oxytocinase. Arch. Gynäk. 191, 57–64 (1958a).
—: Oxytocin und Wehen. Fortschr. Geburtsh. Gynäk. 7, 81–88 (1958b).
—: Das Wehenproblem mit besonderer Berücksichtigung des Oxytocin-Oxytocinasehaushaltes. Z. Geburtsh. Gynäk., Suppl. 154, 1–77 (1960).
—: The significance of oxytocinase in pregnancy and labour. In: Oxytocin, p. 336-340. Proc. Int. Symp., Montevideo 1959, (Pub. 1961).
—: Der Abbau von Hypophysenhinterlappenhormon durch eine Phytooxytocinase. Naturwissenschaften 49, 59 (1962 a).
—: Der Abbau von Hypophysenhinterlappenhormon durch pflanzliche Enzyme. Arzneimittel-Forsch. 12, 252–260 (1962b).
—: Der Abbau von Oxytocin durch menschliche und pflanzliche Enzyme. Geburtsh. u. Frauenheilk. 22, 980–982 (1962c).
—: Serum-Oxytocinase-Aktivität in der Placenta. Arch. Gynäk. 199, 265–270 (1963).
—: Oxytocin: Abbau durch Enzyme. Gynaecologia (Basel) 159, 61–63 (1965).
—: Anstieg der Serum-Oxytocinase-Aktivität im Blut nach 17-α-Hydroxyprogesteronkapro-nat-oder Allylöstrenol-Zufuhr. Arch. Gynäk. 202, 459–461 (1965).
—: Desamino-Oxytocin, ein von Schwangerenblut nicht inaktivierbares Wehenhormon. Geburtsh. u. Frauenheilk. 27, 36–42 (1967).
—, and J. Bernhard: Zur Diagnostik des placentaren Stoffwechsels durch die Serum-Oxyto-cinase-Bestimmung im mütterlichen Blut. Arch. Gynäk. 199, 271–278 (1963).
—, and E. Waidl: Histochemische Untersuchungen über die Serum-Oxytocinase-Bildung im menschlichen Trophoblasten. Z. Geburtsh. Gynäk. 158, 165–171 (1962).
—, and H.-J. Wiendl: Über Oxytocin inaktivierende Gewebeextrakte. Zbl. Gynäk. 84, 1669–1674 (1962).
Siegel, I.A.: Leucine aminopeptidase in pregnancy. Obstet, and Gynec. 14, 488–490 (1959).
Sjöholm, I.: Enzymatic inactivation of oxytocin. Acta chem. scand. 18, 889–898 (1964).
—: Biochemical studies on oxytocin and oxytocinase. Acta pharm. Suecica 4, 81–96 (1967).
—, and G. Rydén: Half-life of oxytocin and lysine-vasopressin in blood of rat at different hormonal stages. Acta pharm. Suecica 4, 23–30 (1967).
—, and Å. Ryrfeldt: A procedure for determination of radioactive metabolites from tritiated oxytocin in tissues. Acta pharm. Suecica 4, 77–80 (1967).
—, and L. Yman: Preparation of highly purified oxytocinase (cystine aminopeptidase) from retroplacental serum. Acta pharm. Suecica 3, 377–388 (1966a). Electrophoretic studies on oxytocinase (cystine aminopeptidase). Relation between electrophoretically found “isozymes”. Acta pharm. Suecica 3, 389-396 (1966b).
Sjöholm, L., and L. Yman: Degradation of oxytocin, lysine-vasopressin, angiotensin II and angiotensin-II-amide by oxytocinase (cystine aminopeptidase). Acta pharm. Suecica 4, 65–76 (1967).
—, and F. Sandberg: Purification of oxytocinase (cystine aminopeptidase) by ethanol fractionation. Acta pharm. Suecica 2, 261–266 (1965).
Smith, E.E., E.P. Pineda, and A.M. Rutenburg: Localization of serum leucine aminopeptidase activity by paper electrophoresis. Proc. Soc. exp. Biol. (N. Y.). 110, 683–687 (1962).
—, and A. M. Rutenburg: Electrophoretic behaviour of an aminopeptidase of human tissues and serum. Nature (Lond.) 197, 800–801 (1963).
Smith, M.W., and H. Sachs: Inactivation of arginine vasopressin by rat-kidney slices. Bio-chem. J. 79, 663–669 (1961).
Smithies, O.: Zone electrophoresis in starch gels and its application to studies of serum proteins. Advanc. Protein Chem. 14, 65–113 (1959).
Spackman, D.H., E.L. Smith, and D.M. Brown: Leucine aminopeptidase. IV. Isolation and properties of the enzyme from swine kidney. J. biol. Chem. 212, 255–269 (1955).
Stepankovskaya, G. K.: The role of oxytocic substances and enzymes destroying them in protracted gestations. Akush. i Ginek. 40, 19–23 (1964). Chem. Abstr. 61, 12465b (1964).
Stoklaska, E., u. E. Wintersberger: Zum Mechanismus des Oxytocin-und Vasopressin-Abbaues durch Schwangerenserum. Arch. Exp. Pathol. Pharmakol. 236, 358–364 (1959).
— Beeinflussung der Oxytocinaseaktivität durch Thymusextrakt. Wien. klin. Wschr. 74, 944–946 (1962).
—: Über die Oxytocinasehemmstoffe im Thymusextrakt. Wien. klin. Wschr. 75, 16–17 (1963).
Suska-Brzezińska, E., and Z. Ewy: Oxytocinase in hen serum. Bull. Acad. pol. Sci., Ser. Sci. Biol. 13, 17–19 (1965).
—, M. Golebska, and Z. Ewy: Biological and chemical determinations of tissue oxytocinase in cows. Acta physiol. pol. 16, 151–158 (1965).
Thorn, N. A.: Some chemical properties of antidiuretic material in the urine of rats. Acta endocr. (Kbh.) 32, 128–133 (1959).
—, and L. Silver: Chemical form of circulating antidiuretic hormone in rats. J. exp. Med. 105, 575–583 (1957).
—, and N.B.S. Willumsen: Inhibitory action of calcium on the inactivation of antidiuretic hormone by rat-kidney slices. Acta endocr. (Kbh.) 44, 563–569 (1963).
Thorpe, W. V.: Experiments on the chemical nature of the oxytocic principle of the pituitary gland. Biochem. J. 20, 374–378 (1926).
Titus, M.A., D.H. Reynolds, M.B. Glendening, and E.W. Page: Plasma aminopeptidase activity (oxytocinase) in pregnancy and labor. Amer. J. Obstet. Gynec. 80, 1124–1128 (1960).
Tuppy, H.: The amino-acid sequence in oxytocin. Biochim. biophys. Acta (Amst.) 11, 449 to 450 (1953).
—: Enzymic inactivation and degradation of oxytocin and vasopressin. In: Polypeptides which affect smooth muscles and blood vessels, p. 49-58. Ed. by M. Schachter. Proc. Symp., London 1959 (Pub. 1960).
—: Biochemical studies of oxytocinase. In: Oxytocin, p. 315-324. Proc. Int. Symp., Montevideo 1959 (Pub. 1961).
—, u. G. Kreil: Über die beim tryptischen Abbau von Pferde-Cytochrom C entstehenden Peptide. Mh. Chem. 93, 780–794 (1962).
—, u. H. Michl: Über die chemische Struktur des Oxytocins. Mh. Chem. 84, 1011–1020 (1953).
—, u. H. Nesvadba: Über die Aminopeptidaseaktivität des Schwangerenserums und ihre Beziehung zu dessen Vermögen, Oxytocin zu inaktivieren. Mh. Chem. 88, 977–988 (1957).
—, U. Wiesbauer u. E. Wintersberger: Aminosäure-p-nitroanilide als Substrate für Aminopeptidasen und andere proteolytische Fermente. Z. Physiol. Chem. 329, 278–288 (1962).
E. Wintersberger —: Über die Einwirkung von Neuraminidase auf die Serumoxytocinase. Mh. Chem. 94, 321–328 (1963).
—, u. E. Wintersberger: Reinigung und Eigenschaften der Serum-Oxytocinase. Mh. Chem. 91, 1001–1010 (1960).
—: Investigations of pregnancy serum oxytocinase. Proc. 2nd Int. Pharmacol. Meeting, Prague 1963, 10, 143–151 (1964).
Du Vigneaud, V., P.S. Fitt, M. Bodanszky, and M. O’connell: Synthesis and somepharma cological properties of a peptide derivative of oxytocin: glycyloxytocin. Proc. Soc. exp. Biol. (N.Y.) 104, 653–656 (1960).
Du Vigneaud, V., H.C. Lawler, and E.A. Popenoe: Enzymatic cleavage of glycinamide from vasopressin and a proposed structure for this pressor antidiuretic hormone of the posterior pituitary. J. Amer. chem. Soc. 75, 4880–4881 (1953).
—, C. Kessler, J.M. Swan, C. W. Roberts, and P.G. Katsoyannis: The synthesis of oxyto-cin. J. Amer. chem. Soc. 76, 3115–3121 (1954).
—, and S. Trippett: The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J. biol. Chem. 205, 949–957 (1953).
Vorherr, H., U. G. Hüskens: Adiuretinabbau und Aminopeptidaseaktivität in Placenta-extrakten. Klin. Wschr. 41, 926–928 (1963).
Werle, E.: Discussion remark. In: Polypeptides which affect smooth muscles and blood vessels, p. 89-90. Ed. by M. Schachter (1960).
—, u. G. Effkemann: Über die oxytocinabbauende Fähigkeit des Schwangerenblutes. Arch. Gynäk. 171, 286–290 (1941).
—, A. Hevelke U. K. Buthmann: Zur Kenntnis des oxytocinabbauenden Prinzips des Blutes. Biochem. Z. 309, 270–282 (1941).
—, u. A. Kalvelage: Über die Vasopressin-inaktivierende Kraft des Blutes von Schwangeren und die Natur des inaktivierenden Prinzips. Biochem. Z. 308, 405–412 (1941).
—, u. L. Maier: Über den Abbau von Oxytocin und Vasopressin durch Milchdrüsenextrakte der Kuh. Naturwissenschaften 41, 380 (1954).
—, u. K. Semm: Aktivitätsbestimmung der Serum-Oxytocinase als Schwangerschaftsnachweis. Klin. Wschr. 29, 544–545 (1951).
—: Methode zur Schwangerschaftsdiagnose mit Bestimmung des Alters der Frucht. Arch. Gynäk. 187, 106–111 (1955).
—: Über die Oxytocinase des Schwangerenblutes. Arch. Gynäk. 187, 449–457 (1956).
—,u. R. Enzenbach: Über die Oxytocinase des Schwangerenblutes und der Erythrocyten. Arch. Gynäk. 177, 211–217 (1950).
Wilken, H.: Die sogenannte „pregnancy zone“, ein neuer Serumfaktor bei Schwangeren. Arch. Gynäk. 199, 243–256 (1963).
Winkhaus, B.: Oxytocinase-Bestimmung bei Kühen unter Berücksichtigung der Bedeutung des Hormons Oxytocin bei der Milchentleerung und Geburtsauslösung. Vet. Med. Diss., München (1954).
Wintersberger, E., u. K.P. Chatterjee: Reinigung und Eigenschaften einer Aminopepti-dase der menschlichen Erythrocyten. Mh. Chem. 93, 1268–1278 (1962).
—, W. Müller-Hartburg U. H. Tuppy: Eine einfache Methode zur chemischen Bestimmung der Oxytocinaseaktivität in Schwangerenseren. Clin. chim. Acta 14, 786–792 (1966).
—, E. Stoklaska, H.D. Moed, U. J. Van Dijk: Substituierte Amide des Cystins als Inhibitoren des Oxytocinabbaues durch die Oxytocinase des Schwangerenserums. Rec. Trav. chim. Pays-Bas 83, 1061–1068 (1964).
—, u. H. Tuppy: Zonen-Elektrophorese von Aminopeptidasen in Stärkegel. Mh. Chem. 91, 406–411 (1960).
—, u. E. Stoklaska: Über ein kompetitives Substrat der Oxytocinase. Mh. Chem. 91, 577–581 (1960).
Woodbury, R.A., R.P. Ahlquist, B. Abreu, R. Torpin, and W.G. Watson: The inactiva-tion of pitocin and pitressin by human pregnancy blood. J. Pharmacol, exp. Ther. 86, 359–365 (1946).
Yano, F.: Antidiuretic substance in the bile. VI. The stability in some digestive juices and digestive enzymes. Yamaguchi Igaku 9, 107–109 (1960).
Yman, L., and I. Sjöholm: Some physicochemical properties of oxytocinase (cystine amino-peptidase). Acta pharm. Suecica 4, 13–22 (1967).
Zamello, J., and J.M. Zgliczynski: Blood peroxidase activity in women in the perinatal period. Ginek. pol. 36, 147–151 (1965).
Zaoral, M., V. Pliška, K. Řežábek, and F. Šorm: Synthesis of two lysine-vasopressin analogues with protracted hormonal activity. Collection Czech. Chem. Commun. 28, 747–749 (1963).
—, and F. Šorm: Preparation and biological activity of some new lysine vasopressin analogues. Proc. 2nd Int. Pharmacol. Meeting, Prague 1963, 10, 167–171 (1964).
—: Amino acids and peptides LV. Synthesis of Gly-Cys1-lysine-vasopressin and Gly-Cys1-Tyr(Me)2-lysine vasopressin. Collection Czech. Chem. Commun. 30, 2812–2816 (1965).
Zasztowt, O.: On the behaviour of oxytocinase during pregnancy. Roczn. Akad. Med. Mar-chlewskiego 9, 3–7 (1963).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1968 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tuppy, H. (1968). The Influence of Enzymes on Neurohypophysial Hormones and Similar Peptides. In: Berde, B. (eds) Neurohypophysial Hormones and Similar Polypeptides. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 23. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46127-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-46127-9_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46129-3
Online ISBN: 978-3-642-46127-9
eBook Packages: Springer Book Archive